Segev Y - Search Results

1

Differential effects on kidney and liver growth of a non-viral hGH-expression vector in hypophysectomized mice.

Khamaisi M, Søndergaard M, Segev Y, Dagnaes-Hansen F, Jensen TG, Landau D, Raz I, Flyvbjerg A. Khamaisi M, et al. Among authors: segev y. Growth Horm IGF Res. 2007 Aug;17(4):279-87. doi: 10.1016/j.ghir.2007.01.018. Epub 2007 Mar 27. Growth Horm IGF Res. 2007. PMID: 17392003

2

Role of insulin and the IGF system in renal hypertrophy in diabetic Psammomys obesus (sand rat).

Raz I, Wexler I, Weiss O, Flyvbjerg A, Segev Y, Rauchwerger A, Raz G, Khamaisi M. Raz I, et al. Among authors: segev y. Nephrol Dial Transplant. 2003 Jul;18(7):1293-8. doi: 10.1093/ndt/gfg170. Nephrol Dial Transplant. 2003. PMID: 12808164

3

Growth hormone receptor antagonism prevents early renal changes in nonobese diabetic mice.

Segev Y, Landau D, Rasch R, Flyvbjerg A, Phillip M. Segev Y, et al. J Am Soc Nephrol. 1999 Nov;10(11):2374-81. doi: 10.1681/ASN.V10112374. J Am Soc Nephrol. 1999. PMID: 10541297

4

Changes in the growth hormone-IGF-I axis in non-obese diabetic mice.

Landau D, Segev Y, Eshet R, Flyvbjerg A, Phillip M. Landau D, et al. Among authors: segev y. Int J Exp Diabetes Res. 2000;1(1):9-18. doi: 10.1155/edr.2000.9. Int J Exp Diabetes Res. 2000. PMID: 11469393 Free PMC article.

5

Growth hormone (GH) hypersecretion and GH receptor resistance in streptozotocin diabetic mice in response to a GH secretagogue.

Johansen PB, Segev Y, Landau D, Phillip M, Flyvbjerg A. Johansen PB, et al. Among authors: segev y. Exp Diabesity Res. 2003 Apr-Jun;4(2):73-81. doi: 10.1155/EDR.2003.73. Exp Diabesity Res. 2003. PMID: 14630569 Free PMC article.

6

Renal hypertrophy in hyperglycemic non-obese diabetic mice is associated with persistent renal accumulation of insulin-like growth factor I.

Segev Y, Landau D, Marbach M, Shehadeh N, Flyvbjerg A, Phillip M. Segev Y, et al. J Am Soc Nephrol. 1997 Mar;8(3):436-44. doi: 10.1681/ASN.V83436. J Am Soc Nephrol. 1997. PMID: 9071712

7

Insulin-like growth factors (IGFs) and IGF-binding proteins in diabetic kidney disease.

Phillip M, Landau D, Segev Y, Weiss O, Raz I. Phillip M, et al. Among authors: segev y. Isr J Med Sci. 1995 Dec;31(12):712-6. Isr J Med Sci. 1995. PMID: 8543465 Review. No abstract available.

8

The effect of growth hormone on the development of diabetic kidney disease in rats.

Landau D, Israel E, Rivkis I, Kachko L, Schrijvers BF, Flyvbjerg A, Phillip M, Segev Y. Landau D, et al. Among authors: segev y. Nephrol Dial Transplant. 2003 Apr;18(4):694-702. doi: 10.1093/ndt/gfg142. Nephrol Dial Transplant. 2003. PMID: 12637637

9

A novel somatostatin analogue prevents early renal complications in the nonobese diabetic mouse.

Landau D, Segev Y, Afargan M, Silbergeld A, Katchko L, Podshyvalov A, Phillip M. Landau D, et al. Among authors: segev y. Kidney Int. 2001 Aug;60(2):505-12. doi: 10.1046/j.1523-1755.2001.060002505.x. Kidney Int. 2001. PMID: 11473633 Free article.

10

Involvement of the skeletal GH-IGF system in an experimental model of diabetes-induced growth retardation.

Segev Y, Landau D, Davidoff-Friedman S, Weinreb M, Phillip M. Segev Y, et al. Acta Diabetol. 2002 Jun;39(2):61-7. doi: 10.1007/s005920200015. Acta Diabetol. 2002. PMID: 12120915

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

231 results

Search Page

Filters